All tenders
75N93024C00008
TO DEVELOP A NOVEL MODULATOR TARGETING PROTEOSTASIS FOR THE TREATMENT OF M. TUBERCULOSIS.
National Institutes of Health · United States
This contract has been awarded. Browse open opportunities
Time Left to Bid
Awarded
AwardedOtherFederal
Basic information
- Reference number
- 75N93024C00008
- Issuing organization
- National Institutes of Health · Find award history →
- Government level
- Federal
- Solicitation type
- Other
- Title
- TO DEVELOP A NOVEL MODULATOR TARGETING PROTEOSTASIS FOR THE TREATMENT OF M. TUBERCULOSIS.
- Source
- USASpending (Federal)
- Source ID
- usa-75N93024C00008
Details
- Location
- United States
Description
TO DEVELOP A NOVEL MODULATOR TARGETING PROTEOSTASIS FOR THE TREATMENT OF M. TUBERCULOSIS. Awarded to: THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT INC Agency: Department of Health and Human Services Sub-agency: National Institutes of Health Award type: DEFINITIVE CONTRACT
Dates
- Publication
- 2024/05/10 12:00:00 AM UTC
- Closing date
- 2027/02/28 12:00:00 AM UTC
Estimated value
$2.5M USD
Classification
Normalized category
Other